Sara Bonstein - 14 Jun 2022 Form 4 Insider Report for scPharmaceuticals Inc. (SCPH)

Role
Director
Signature
/s/ John H. Tucker, as Attorney-in-Fact
Issuer symbol
SCPH
Transactions as of
14 Jun 2022
Net transactions value
$0
Form type
4
Filing time
15 Jun 2022, 16:30:41 UTC
Previous filing
18 May 2022
Next filing
17 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SCPH Stock Option (right to buy) Award $0 +16,300 $0.000000 16,300 14 Jun 2022 Common Stock 16,300 $4.53 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This stock option vests in full upon the earlier of (i) June 14, 2023, or (ii) the next annual meeting of the Issuer's stockholders.